Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study

Feng Bi(Tianjin University of Traditional Chinese Medicine), Jiayuan Wu(Guangdong Medical College), Senming Wang(Southern Medical University), Zhenggang Ren(Ministry of Education of the People's Republic of China), Xuelong Zhuang(Shantou University), Zhendong Zheng(General Hospital of Shenyang Military Region), Xi Chen(Fuzhou General Hospital of Nanjing Military Command), Longzhen Zhang(Xuzhou Medical College), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Jifang Sheng(Zhejiang Shuren University), Qingxia Fan(First Affiliated Hospital of Zhengzhou University), Yinying Lu(Chinese PLA General Hospital), Xiaoli Xin(Xijing Hospital), Jianming Xu(ZheJiang Academy of Agricultural Sciences), Jian Wu, Yuxian Bai(Harbin Medical University), Chengxu Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongming Pan, Yongping Chen(Wenzhou Medical University), Ping Yang(Chinese PLA General Hospital), Junhui Chen(Peking University Shenzhen Hospital), Zhendong Chen(Anhui Medical University), Aibing Xu(Nantong Tumor Hospital), Xiaoyu Wen(Jilin University), Chengyou Du(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shukui Qin(China Pharmaceutical University), Da Jiang(Hebei Medical University), Bo Zhu(Zhongshan People's Hospital), Jinlu Shan(Army Medical University), Li Xu(Sun Yat-sen University), Zhenyu You(General Hospital of Shenyang Military Region), Zhiqiang Meng(Fudan University Shanghai Cancer Center), Jufeng Wang(Zhengzhou University), Helong Zhang(Shanghai International Studies University)
European journal of medical research
October 29, 2025
Cited by 1


Related Papers